THE USE OF PACLITAXEL IN CHEMORADIOTHERAPY OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A PILOT STUDY
Objectives: to assess the feasibility of a combination of the intensity-modulated radiation therapy (IMRT) with a triplet chemotherapy with paclitaxel, capecitabine, and mitomycin C in the treatment of patients with anal cancer, and to evaluate the toxicity of the proposed treatment regimen.Material...
Main Authors: | S. S. Gordeev, V. A. Gorbunova, S. I. Tkachev, V. V. Glebovskaya, N. S. Besova, Yu. E. Suraeva, M. Yu. Fedyanin, V. A. Ivanov, V. S. Anan’ev, A. G. Malikhov, A. O. Rasulov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
“ABV-press” Publishing house”, LLC
2017-01-01
|
Series: | Тазовая хирургия и онкология |
Subjects: | |
Online Access: | https://ok.abvpress.ru/jour/article/view/187 |
Similar Items
-
Anal cancer with large metastases into the perirectal fat: differential diagnosis and treatment policy
by: A. O. Rasulov, et al.
Published: (2016-01-01) -
role of telehealth services in the treatment of rare disease: analysis of 1 year of work on the example of anal cancer
by: S. S. Gordeev, et al.
Published: (2020-08-01) -
Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal
by: V V Glebovskaya, et al.
Published: (2017-06-01) -
Сombined treatment of squamous-cell anal cancer
by: D. F. Kim, et al.
Published: (2015-02-01) -
Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis
by: Qiong Yi, et al.
Published: (2023-03-01)